Olsen, Lone Stengelshøj <br/><br/>
Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity.  [electronic resource] 

 -  International journal of cancer  Aug 2004 
 - 198-205 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.20255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung<br/>Carcinoma, Small Cell--pathology<br/>Cell Division<br/>Cyanides--pharmacology<br/>Down-Regulation<br/>Female<br/>Guanidines--pharmacology<br/>Humans<br/>I-kappa B Kinase<br/>Lung Neoplasms--pathology<br/>Mice<br/>NF-kappa B--metabolism<br/>Protein Serine-Threonine Kinases--pharmacology<br/>Transplantation, Heterologous<br/>Tumor Cells, Cultured